Evidence map›Paper›PMID 42889868›Full record

ArticleBiomedical optics express2026

Deep-learning-aided sarcoma biopsy guidance using forward-view endoscopic optical coherence tomography.

Haoyang Cui, Chen Wang, Kar-Ming Fung, Ajay Jain, Paul Calle, Ronghao Liu, Junyuan Liu, Yan Cui, Qinghao Zhang, Yuye Ling and 3 more

Abstract read
In one paragraph

Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Haoyang CuiSchool of Computer Science, Gallogly College of Engineering, University of Oklahoma, Norman, OK 73019, USA.ORCID https://orcid.org/0009-0009-8708-5556
Chen WangStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.ORCID https://orcid.org/0000-0003-4645-3227
Kar-Ming FungStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Ajay JainStephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, USA.
Paul CalleSchool of Computer Science, Gallogly College of Engineering, University of Oklahoma, Norman, OK 73019, USA.
Ronghao LiuStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.
Junyuan LiuStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.
Yan CuiStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.
Qinghao ZhangStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.ORCID https://orcid.org/0009-0005-2906-6315
Yuye LingSchool of Electrical and Computer Engineering, University of Oklahoma, Norman, OK 73019, USA.ORCID https://orcid.org/0000-0002-4628-7604
Jeremy WhiteDepartment of Orthopedic Surgery, University of Oklahoma College of Medicine, Oklahoma City, OK 73104, USA.
Qinggong TangStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK 73019, USA.ORCID https://orcid.org/0000-0001-9499-5384
Chongle PanSchool of Computer Science, Gallogly College of Engineering, University of Oklahoma, Norman, OK 73019, USA.

Funding

Tissue Pathology Shared ResourceP30CA225520 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michael S. Businelle · 2018 to 2026
$27.1M
Use of 3D Quantitative Optical Methods to Optimize Mebendazole Treatment of Ovarian CancerP20GM135009 · NIGMS · UNIVERSITY OF OKLAHOMA · PI Javier Antonio Jo · 2022 to 2026
$13.6M
Automatic Wide-Field Optical Coherence Tomography for Assessment of Transplant Kidney ViabilityR01DK133717 · NIDDK · UNIVERSITY OF MASSACHUSETTS AMHERST · PI POTTER, STEVEN, TANG, QINGGONG · 2022 to 2025
$2.5M
NCI NIH HHS P30 CA225520NIDDK NIH HHS R01 DK133717NIGMS NIH HHS P20 GM135009
6 · The paper itself

Abstract

Sarcoma diagnosis remains challenging due to tumor heterogeneity and the risk of sampling errors during biopsy, as tissue misidentification can result in non-diagnostic outcomes and repeated procedures. This study specifically targets undifferentiated pleomorphic sarcoma (UPS) and myxofibrosarcoma, imaged in specimens from the human arms and legs. Optical coherence tomography (OCT) offers high-resolution, real-time microstructural imaging and has shown strong potential for image-guided oncology. In this study, we benchmarked five 2D deep learning models and one custom 3D convolutional neural network (CNN) for normal versus tumor tissues classification using endoscopic OCT. The 2D models were applied to cross-sectional 2D images while the 3D CNN operated on volumetric images, with both evaluated across the Intensity and polarization-sensitive OCT channels (PS-OCT). 3D CNN reached the highest accuracy of 92.67% on Intensity, while PS-OCT channels benefited more from modern 2D architectures and 3D volumetric modeling, with performance gains up to 9.63% for the optic axis. These results demonstrated the feasibility of endoscopic OCT as a real-time, label-free tissue characterization tool during biopsy of these sarcoma tissues. The integration of deep learning with forward-viewing endoscopic OCT offers a promising pathway toward more accurate needle guidance and reduced diagnostic failure rates and established a reproducible benchmarking framework for future OCT-based detection and analysis of sarcoma tissues.

Identifiers

PMID42889868
PMCPMC13671704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.